This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Plexin-A1.
Coreceptor for SEMA3A, SEMA3C, SEMA3F and SEMA6D.
Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton.Plays a role in axon guidance, invasive growth and cell migration. Class 3 semaphorins bind to a complex composed of a neuropilin and a plexin.
Human | |
---|---|
Gene Name: | PLXNA1 |
Uniprot: | Q9UIW2 |
Entrez: | 5361 |
Belongs to: |
---|
plexin family |
NOV; NOVP; Plexin A1; PLEXIN-A1; PLXN1; PLXNA1
Mass (kDA):
211.067 kDA
Human | |
---|---|
Location: | 3q21.3 |
Sequence: | 3; NC_000003.12 (126983259..127037392) |
Detected in fetal brain, lung, liver and kidney.
Cell membrane; Single-pass type I membrane protein.
Are you interested to learn more about the PLXNA1Marker? This article will provide information about Boster and the history of the antigen. We'll also discuss the uses of this marker in various biological settings. Read on for more information! Click the links below to learn more about Boster’s research. This article is written for scientists, researchers, and the general public.
The Anti-Plexin A1 ELISA kit from Boster Bio can be used for detection of human Plexin A1. It is tested for its ability to detect human Plexin A1 in ICC, WB, and flow cytometry. This kit was able to react with human, mouse, and rat cells. The Technical Information section of Boster Bio's website lists the dilutions used.
Plexin A1 (200 kDa) is a transmembrane type I transmembrane proteins. It belongs to the family of Semaphorin signal transducers. It regulates many processes in cells, including neuronal and axon development, as well as anti-angiogenesis. This marker is highly specific and allows for precise analysis of biological processes.
Several suppliers offer Anti-Plexin A1 ELISA kits. The antibody is a monoclonal antibody against PLXNA1, a protein found in many cell types. It is one member of a family that includes nine other proteins. It is involved in the signaling growth factors. It is activated in growth cones and causes destabilization of microtubules and actin. The protein has been shown to be non-toxic in hUC-MSCs up to 2 mg/mL and 3 mg/mL.
The LISSV-related virus infection resulted in a reduction in the expression levels of PLXNA4 (and other neuronal genes). LISSV, a Semaphorin 3A-dependent PLEXNA4 ligand, activated SEMA3A and FYN, a downstream signaling molecule. This study indicates that PLXNA4-PLXNA4-mediated FYN activation is important in hUC-MSC neuronal differentiation.
The PLXNA1 genome is present in humans and mice. It is involved with the development of the neuroendocrine axis and is responsible for organizing olfactory-associated Axonal tracts. It also guides GnRH–synthesizing neural cells. Further studies are needed to determine its function and its role in the development of human corticospinal systems.
There are two possible explanations for the regulation PLXNA1 or MAPK signalling pathways. One is that miR134 may be involved with the development of ESCC. Effective inhibitors of MAPK signalling pathways are effective at inhibiting tumour growth. MiR-134 also inhibits PLXNA1 transcription. ESCC may also be a target.
PLXNA1 is a protein that is expressed by the prostate gland. It plays a vital role in prostate cell proliferation, invasion, and metastasis. High levels of this protein in prostate cancer cells are associated with a higher risk of malignancy. Studies using this protein are important in early detection and risk assessment for prostate cancer. The protein is also used to make pharmaceuticals for the treatment and prevention of prostate cancer.
In the present invention, the PLXNA1 biomarker was identified as an independent risk factor for prostate cancer. This marker could differentiate between high-risk or low-risk prostate carcinoma. This marker is useful for screening and detection prostate cancer, and other high-risk malignancies. The present invention can be classified as a diagnostic, therapeutic, or biomarker. Among these, PLXNA1 represents a new and important molecule within the field of Biomedicine.
Metastatic prostate cancer is a common place where PLXNA1 expression is high. It is also related with overall survival after radical surgical and non-metastatic forms of prostate cancer. The present inventors studied whether an increase in PLXNA1 copy number correlates with higher malignancy. Further, they examined whether the PLXNA1 genome copy number is directly linked to prostate cancer recurrence. The PLXNA1 gene number could be used to assess prostate cancer malignancy.
The protein is also used to grow cells in addition the previously mentioned uses. Overexpression PLXNA1 is a significant factor in cell proliferation, invasion and migration. The invasion and migration experiments were performed on prostate cancer cells that were grown in 6-well plates. They were transfected with Lipofectamine 2000, which contains 4 ug of the plasmid. The cells were cultured in the exact same way as in 1.1 following transfection.
PMID: 8570614 by Maestrini E., et al. A family of transmembrane proteins with homology to the MET- hepatocyte growth factor receptor.